Literature DB >> 31630758

Recent insights into innate and adaptive immune responses to Giardia.

Steven M Singer1, Marc Y Fink2, Vanessa V Angelova2.   

Abstract

Infection with Giardia produces a wide range of clinical outcomes. Acutely infected patients may have no overt symptoms or suffer from severe cramps, diarrhea, nausea and even urticaria. Recently, post-infectious irritable bowel syndrome and chronic fatigue syndrome have been identified as long-term sequelae of giardiasis. Frequently, recurrent and chronic Giardia infection is considered a major contributor to stunting in children from low and middle income countries. Perhaps the most unusual outcome of infection with Giardia is the apparent reduced risk of developing moderate-to-severe diarrhea due to other enteric infections which has been noted in several recent studies. The goal of understanding immune responses against Giardia is therefore to identify protective mechanisms which could become targets for vaccine development, but also to identify mechanisms whereby infections lead to these other diverse outcomes. Giardia induces a robust adaptive immune response in both humans and animals. It has been known for many years that there is production of large amounts of parasite-specific IgA following infection and that CD4+ T cell responses contribute to this IgA production and control of the infection. In the past decade, there have been advances in our understanding of the non-antibody effector mechanisms used by the host to fight Giardia infections, in particular the importance of the cytokine interleukin (IL)-17 in orchestrating these responses. There have also been major advances in understanding how the innate response to Giardia infection is initiated and how it contributes to the development of adaptive immunity. Finally, there here have been significant increases in our knowledge of how the resident microbial community influences the immune response and how these responses contribute to the development of some of the symptoms of giardiasis. In this article, we will focus on data generated in the last 10 years and how it has advanced our knowledge about this important parasitic disease.
© 2019 Elsevier Ltd All rights reserved.

Entities:  

Keywords:  Dendritic cells; Giardia; IL-17; Immunity; Macrophage; Mast cells; Microbiome

Mesh:

Substances:

Year:  2019        PMID: 31630758      PMCID: PMC7086480          DOI: 10.1016/bs.apar.2019.07.004

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  10 in total

1.  Changes in Systemic Regulatory T Cells, Effector T Cells, and Monocyte Populations Associated With Early-Life Stunting.

Authors:  Zo Andriamanantena; Fanirisoa Randrianarisaona; Maheninasy Rakotondrainipiana; Prisca Andriantsalama; Ravaka Randriamparany; Rindra Randremanana; Frédérique Randrianirina; Sophie Novault; Darragh Duffy; François Huetz; Milena Hasan; Matthieu Schoenhals; Philippe J Sansonetti; Pascale Vonaesch; Inès Vigan-Womas
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

2.  Giardia lamblia: Laboratory Maintenance, Lifecycle Induction, and Infection of Murine Models.

Authors:  Marc Y Fink; Danielle Shapiro; Steven M Singer
Journal:  Curr Protoc Microbiol       Date:  2020-06

3.  Giardiasis reactivation during severe SARS-CoV-2 infection.

Authors:  Tommaso Lupia; Silvia Corcione; Francesco G De Rosa
Journal:  Parasitol Int       Date:  2020-11-05       Impact factor: 2.230

Review 4.  Giardia spp. and the Gut Microbiota: Dangerous Liaisons.

Authors:  Elena Fekete; Thibault Allain; Affan Siddiq; Olivia Sosnowski; Andre G Buret
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

5.  Conserved metabolic enzymes as vaccine antigens for giardiasis.

Authors:  Sozaburo Ihara; Yukiko Miyamoto; Christine H Y Le; Vivien N Tran; Elaine M Hanson; Marvin Fischer; Kurt Hanevik; Lars Eckmann
Journal:  PLoS Negl Trop Dis       Date:  2022-04-25

Review 6.  Intestinal immune responses to commensal and pathogenic protozoa.

Authors:  Aline Sardinha-Silva; Eliza V C Alves-Ferreira; Michael E Grigg
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

7.  The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation in a Structure-Dependent Fashion via Toll-like Receptors.

Authors:  Cynthia Fernández-Lainez; Ignacio de la Mora-de la Mora; Sergio Enríquez-Flores; Itzhel García-Torres; Luis A Flores-López; Pedro Gutiérrez-Castrellón; Paul de Vos; Gabriel López-Velázquez
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

8.  Update on Giardia: Highlights from the seventh International Giardia and Cryptosporidium Conference.

Authors:  André G Buret; Simone M Cacciò; Loïc Favennec; Staffan Svärd
Journal:  Parasite       Date:  2020-08-13       Impact factor: 3.000

9.  Serglycin-Deficiency Causes Reduced Weight Gain and Changed Intestinal Cytokine Responses in Mice Infected With Giardia intestinalis.

Authors:  Zhiqiang Li; Dimitra Peirasmaki; Staffan Svärd; Magnus Åbrink
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

10.  Giardia duodenalis and Its Secreted PPIB Trigger Inflammasome Activation and Pyroptosis in Macrophages through TLR4-Induced ROS Signaling and A20-Mediated NLRP3 Deubiquitination.

Authors:  Lin Liu; Yongwu Yang; Rui Fang; Weining Zhu; Jingxue Wu; Xiaoyun Li; Jay V Patankar; Wei Li
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.